K M Kampman

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. ncbi Reliability and validity of the Cocaine Selective Severity Assessment
    K M Kampman
    University of Pennsylvania School of Medicine, Philadelphia, USA
    Addict Behav 23:449-61. 1998
  2. ncbi Open trials as a method of prioritizing medications for inclusion in controlled trials for cocaine dependence
    K M Kampman
    Department of Psychiatry, University of Pennsylvania School of Medicine, USA
    Addict Behav 24:287-91. 1999
  3. ncbi Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment
    K M Kampman
    University of Pennsylvania Treatment Research Center, 3900 Chestnut Street, Philadelphia, Pennsylvania 19104, USA
    Psychol Addict Behav 15:52-9. 2001
  4. ncbi Amantadine in the treatment of cocaine-dependent patients with severe withdrawal symptoms
    K M Kampman
    Department of Psychiatry, University of Pennsylvannia School of Medicine, Philadelphia, 19104, USA
    Am J Psychiatry 157:2052-4. 2000
  5. ncbi Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity
    K M Kampman
    Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Drug Alcohol Depend 63:69-78. 2001
  6. ncbi The effects of naltrexone on alcohol and cocaine use in dually addicted patients
    D W Oslin
    Department of Psychiatry, University of Pennsylvania, Philadelphia, USA
    J Subst Abuse Treat 16:163-7. 1999
  7. ncbi Case-control association analysis of polymorphisms in the delta-opioid receptor, OPRD1, with cocaine and opioid addicted populations
    R C Crist
    Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Drug Alcohol Depend 127:122-8. 2013
  8. ncbi Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction
    T K Clarke
    Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania School of Medicine, 125 South 31st Street, Philadelphia, PA 19104, USA
    Genes Brain Behav 11:415-23. 2012
  9. ncbi Tolerance and sensitization to the effects of cocaine use in humans: a retrospective study of long-term cocaine users in Philadelphia
    A C Small
    Treatment Research Center, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Subst Use Misuse 44:1888-98. 2009

Collaborators

Detail Information

Publications9

  1. ncbi Reliability and validity of the Cocaine Selective Severity Assessment
    K M Kampman
    University of Pennsylvania School of Medicine, Philadelphia, USA
    Addict Behav 23:449-61. 1998
    ..The CSSA appears to be a reliable and valid measure of cocaine abstinence symptoms and a useful predictor of negative outcomes in cocaine dependence treatment...
  2. ncbi Open trials as a method of prioritizing medications for inclusion in controlled trials for cocaine dependence
    K M Kampman
    Department of Psychiatry, University of Pennsylvania School of Medicine, USA
    Addict Behav 24:287-91. 1999
    ..We conclude that propranolol may enhance retention among cocaine-dependent patients, especially among those who also abuse alcohol. These results encourage a double-blind, placebo-controlled trial of propranolol...
  3. ncbi Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment
    K M Kampman
    University of Pennsylvania Treatment Research Center, 3900 Chestnut Street, Philadelphia, Pennsylvania 19104, USA
    Psychol Addict Behav 15:52-9. 2001
    ..The presence of cocaine withdrawal symptoms and a positive urine toxicology screen are clinically useful predictors of treatment attrition...
  4. ncbi Amantadine in the treatment of cocaine-dependent patients with severe withdrawal symptoms
    K M Kampman
    Department of Psychiatry, University of Pennsylvannia School of Medicine, Philadelphia, 19104, USA
    Am J Psychiatry 157:2052-4. 2000
    ..The study examined the effectiveness of amantadine in reducing cocaine withdrawal symptoms and improving treatment outcome among cocaine-dependent patients in outpatient treatment...
  5. ncbi Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity
    K M Kampman
    Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Drug Alcohol Depend 63:69-78. 2001
    ..Propranolol may be useful only for the treatment of cocaine dependent patients with severe cocaine withdrawal symptoms...
  6. ncbi The effects of naltrexone on alcohol and cocaine use in dually addicted patients
    D W Oslin
    Department of Psychiatry, University of Pennsylvania, Philadelphia, USA
    J Subst Abuse Treat 16:163-7. 1999
    ..The results of this study provide a rationale for a double-blind placebo-controlled study of the efficacy of naltrexone in this difficult to treat but prevalent population...
  7. ncbi Case-control association analysis of polymorphisms in the delta-opioid receptor, OPRD1, with cocaine and opioid addicted populations
    R C Crist
    Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    Drug Alcohol Depend 127:122-8. 2013
    ..The MOR, however, interacts with and is regulated by many known MOR interacting proteins (MORIPs), including the δ-opioid receptor (DOR)...
  8. ncbi Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction
    T K Clarke
    Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania School of Medicine, 125 South 31st Street, Philadelphia, PA 19104, USA
    Genes Brain Behav 11:415-23. 2012
    ..These data show that polymorphisms in PDYN are associated with opioid addiction in EAs and provide further evidence that these risk variants may be more relevant in females...
  9. ncbi Tolerance and sensitization to the effects of cocaine use in humans: a retrospective study of long-term cocaine users in Philadelphia
    A C Small
    Treatment Research Center, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Subst Use Misuse 44:1888-98. 2009
    ..The data provide preliminary evidence for the hedonic dysregulation model of addiction. Limitations and implications of the study are discussed in the conclusion...